Acipimox [CAS 51037-30-0]
Partner: MedChemexpress LLC
| CAS No: | 51037-30-0 |
| Applications: | COVID-19-immunoregulation |
| MW: | 154.12 |
| Formula: | C6H6N2O3 |
| SMILES: | O=C(C1=C[N+]([O-])=C(C)C=N1)O |
| Purity: | 99.86 |
| Description: | Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity[1][2][3]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
